Wells Fargo’s Enlivex Therapeutics ENLV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.3K | Hold |
|
|||||
|
2025
Q1 | $8.91K | Hold |
|
|||||
|
2024
Q4 | $10.7K | Hold |
|
|||||
|
2024
Q3 | $15.4K | Hold |
|
|||||
|
2024
Q2 | $13K | Sell |
|
|||||
|
2024
Q1 | $37.9K | Hold |
|
|||||
|
2023
Q4 | $27K | Buy |
|
|||||
|
2023
Q3 | $14K | Hold |
|
|||||
|
2023
Q2 | $23.3K | Sell |
|
|||||
|
2023
Q1 | $38.9K | Sell |
|
|||||
|
2022
Q4 | $46.3K | Sell |
|
|||||
|
2022
Q3 | $77K | Buy |
|
|||||
|
2022
Q2 | $56K | Sell |
|
|||||
|
2022
Q1 | $87K | Buy |
|
|||||
|
2021
Q4 | $76K | Sell |
|
|||||
|
2021
Q3 | $130K | Sell |
|
|||||
|
2021
Q2 | $174K | Buy |
|
|||||
|
2021
Q1 | $199K | Buy |
|
|||||
|
2020
Q4 | $2K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $1K | Hold |
|
|||||
|
2015
Q3 | $2K | Hold |
|
|||||
|
2015
Q2 | $2K | Sell |
|
|||||
|
2015
Q1 | $5K | Buy |
|